Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Martin

Showing results (71-80 of 133) with videos related to

Pageof 14
Sort By:
British Journal of Haematology|August 30, 2022
Antibody and T-cell responses by ultra-deep T-cell receptor immunosequencing after COVID-19 vaccination in patients with plasma cell dyscrasiasAlfred Chung, Barbara Banbury, Marissa Vignali, et al.
Journal of the American Heart Association|December 18, 2023
Dysregulated Autophagy and Sarcomere Dysfunction in Patients With Heart Failure With Co-Occurrence of P63A and P380S <i>BAG3</i> VariantsThomas G Martin, Hana Pak, Glenn S Gerhard, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell TransplantationMatthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Cells|November 30, 2019
Therapeutic Opportunities with Pharmacological Inhibition of CD38 with IsatuximabThomas G Martin, Kathryn Corzo, Marielle Chiron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2020
Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple MyelomaDaniel W Sherbenou, Yang Su, Christopher R Behrens, et al.
Nature Communications|December 5, 2020
Revealing the structures of megadalton-scale DNA complexes with nucleotide resolutionMassimo Kube, Fabian Kohler, Elija Feigl, et al.
Transplantation and Cellular Therapy|November 13, 2022
Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis by Prior TransplantationThomas G Martin, Marcelo Capra, Mohamad Mohty, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell TransplantationMariam T Nawas, Charalambos Andreadis, Thomas G Martin, et al.
Cancer|November 14, 2023
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 studyAjay K Nooka, Cesar Rodriguez, María Victoria Mateos, et al.
Transplantation and Cellular Therapy|March 5, 2022
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older AdultsLi-Wen Huang, Ying Sheng, Charalambos Andreadis, et al.
Pageof 14

Showing results (71-80 of 133) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|August 30, 2022
Antibody and T-cell responses by ultra-deep T-cell receptor immunosequencing after COVID-19 vaccination in patients with plasma cell dyscrasiasAlfred Chung, Barbara Banbury, Marissa Vignali, et al.
Journal of the American Heart Association|December 18, 2023
Dysregulated Autophagy and Sarcomere Dysfunction in Patients With Heart Failure With Co-Occurrence of P63A and P380S <i>BAG3</i> VariantsThomas G Martin, Hana Pak, Glenn S Gerhard, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2016
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell TransplantationMatthew P Mulé, Gabriel N Mannis, Brent L Wood, et al.
Cells|November 30, 2019
Therapeutic Opportunities with Pharmacological Inhibition of CD38 with IsatuximabThomas G Martin, Kathryn Corzo, Marielle Chiron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2020
Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple MyelomaDaniel W Sherbenou, Yang Su, Christopher R Behrens, et al.
Nature Communications|December 5, 2020
Revealing the structures of megadalton-scale DNA complexes with nucleotide resolutionMassimo Kube, Fabian Kohler, Elija Feigl, et al.
Transplantation and Cellular Therapy|November 13, 2022
Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis by Prior TransplantationThomas G Martin, Marcelo Capra, Mohamad Mohty, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 2, 2019
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell TransplantationMariam T Nawas, Charalambos Andreadis, Thomas G Martin, et al.
Cancer|November 14, 2023
Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 studyAjay K Nooka, Cesar Rodriguez, María Victoria Mateos, et al.
Transplantation and Cellular Therapy|March 5, 2022
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older AdultsLi-Wen Huang, Ying Sheng, Charalambos Andreadis, et al.
Pageof 14